ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL

Authors

• Suresh G. Nair MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2023

Volume

25

Issue

5

Published In/Presented At

 https://doi.org/10.1093/neuonc/noad179.0259

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article